Researchers from the University of Chicago have created a new vaccine that can effectively treat these debilitating diseases in a way that doesn’t require suppressing the entire immune system and thus prevents a variety of negative side effects.
The breakthrough from researchers at NYU Langone is a promising step toward using non-human donors for organ transplants, a possible answer to an ongoing organ shortage that has plagued the U.S. and other countries for years.
The new vaccine developed by the International Vaccine Institute, Gotovax, and Valneva Sweden is low-cost, lasts longer than alternatives, and is easier and cheaper to deliver around the globe. Cholera kills more than 100,000 people worldwide every year.
The experiment from the Guangzhou Institute of Biomedicine and Health experiment grew humanized kidneys in pig embryos. It represents a key step toward building an inexhaustible source of organs for transplants.
Liquefied natural gas (LNG) transport by rail exposes nearby communities to the risk of destructive explosions, choking clouds, and uncontrollable fires and accelerates the burning of fossil fuels.
Phase 1 trials, which will take place at Columbia University in New York City and are expected to start in early 2024, will see participants who are already using these drugs take increasing doses of the vaccines to ensure it’s safe.
While the life expectancy has risen on average 2.2 years since 2013, some cities have seen far more drastic increases. Citizens living under the new “Beijing Blue,” are predicted to live 4 more years, while those 11 million in Baoding are predicted to gain 6 years.
Researchers from Monash University, Cleveland Clinic, and Eli Lilly have developed an oral drug to target a form of cholesterol that has previously been untreatable and is largely caused by genetics.
In a study at the UK’s Nottingham Trent University, biomedical scientist Biola Egbowon and colleagues used nanotechnology to successfully treat macular degeneration.
The latest technology from the UC-San Francisco uses tiny electrodes implanted on the surface of the brain to detect electrical activity in the part of the brain that controls speech and face movements.
